| 222 | 3 | 30 |
| 下载次数 | 被引频次 | 阅读次数 |
目的:探讨糖皮质激素相关性中心性浆液性脉络膜视网膜病变(CSC)的临床特点及中西医治疗策略。方法:对1例因眼部炎症指征误诊为葡萄膜炎的双眼慢性CSC患者的诊疗经过进行分析。结果:本例患者因双眼视物模糊3个月就诊。根据病史、临床表现、眼科检查、辅助检查、试验性激素治疗及停激素改中药治疗后,患者病情明显好转,确诊为CSC。结论:激素相关性CSC常见于双边、非典型性CSC,治疗上应禁用激素,采用中医辨证论治,围绕"湿"与"虚"治以健脾除湿,采用参苓白术散加减疗效显著。
Abstract：[1]梁丽娜，王志强，马纳，等．防风对六味地黄丸干预实验性视网膜变性作用的影响[J]．中国中医眼科杂志，2013,23(5):313-317.
[2]徐昌标，孙祖华，黄颖，等．中心性浆液性脉络膜视网膜病变患者外源性糖皮质激素使用情况调查[J]．中华眼底病杂志，2019,35(4):387-389.
[3] WAKAURA M,ISHIKAWA S. Central serous chorioretinopathy complicating systemic corticosteroid treatment[J].Br J Ophthalmol,1984,68(5):329-331.
[4]张晓霞，张文芳，王玉萍，等．误诊为Vogt-小柳原田综合征的中心性浆液性脉络膜视网膜病变一例[J]．眼科，2019,28(5):396-397.
[5] LENK J,SANDNER D,SCHINDLER L,et al. Hair cortisol concentration in patients with active central serous chorioretinopathy is elevated-a pilot study[J]. Acta Ophthalmol,2019,97(4):e568-e571.
[6] RIM T H,KIM H S,KWAK J,et al. Association of corticosteroid use with incidence of central serous chorioretinopathy in South Korea[J]. JAMA Ophthalmol,2018,136(10):1164-1169.
[7] ERSOZ M G,ARF S,HOCAOGLU M,et al. Patient characteristics and risk factors for central serous chorioretinopathy:an analysis of 811 patients[J]. Br J Ophthalmol,2019,103(6):725-729.
[8] LIANG Z Q,HUANG L Z,QU J F,et al. Association between endogenous cortisol level and the risk of central serous chorioretinopathy:a Meta-analysis[J]. Int J Ophthalmol,2018,11(2):296-300.
[9] LIEW G,QUIN G,GILLIES M,et al. Central serous chorioretinopathy:a review of epidemiology and pathophysiology[J].Clin Exp Ophthalmol,2013,41(2):201-214.
[10] RUEDA-RUEDA T,SANCHEZ-VICENTE J L,LLERENAMANZORRO L,et al. Bilateral exudative retinal detachment associated with central serous chorioretinopathy in a patient treated with corticosteroids[J]. Arch Soc Esp Oftalmol,2017,92(10):481-485.
[11] BRINKS J,VAN DIJKE H C,HABEEB M,et al. The effect of corticosteroids on human choroidal endothelial cells:a model to study central serous chorioretinopathy[J].Invest Ophthalmol Vis Sci,2018,59(13):5682-5692.
[12] CILOGLU E,UNAL F,DOGAN N C. The relationship between the central serous chorioretinopathy,choroidal thickness,and serum hormone levels[J]. Graefes Arch Clin Exp Ophthalmol,2018,256(6):1111-1116.
[13] ARAKI T,ISHIKAWA H,IWAHASHI C,et al. Central serous chorioretinopathy with and without steroids:A multicenter survey[J]. PLoS One,2019,14(2):e0213110.
[14]林杜生，张贵华，陈浩宇，等．频域OCT在急性Vogt-小柳原田病和急性中心性浆液性脉络膜视网膜病变鉴别诊断中的应用[J]．眼科新进展，2015,35(6):557-560.
[15] SAHOO N K,SINGH S R,RAJENDRAN A,et al. Masqueraders of central serous chorioretinopathy[J]. Surv Ophthalmol,2019,64(1):30-44.
[16]刘卫华，杨新怀，黄勤，等．OCT与FFA在中心性浆液性脉络膜视网膜病变检查中的应用比较[J]．眼科新进展，2013,33(9):867-869.
[17] GE G,ZHANG Y,ZHANG Y,et al.Corticosteroids usage and central serous chorioretinopathy:a meta-analysis[J].Graefes Arch Clin Exp Ophthalmol,2020,258(1):71-77.
基本信息:
DOI：10.16295/j.cnki.0257-358x.2022.02.016
中图分类号:R276.7
引用信息:
[1]范文娜,魏伟,宋玉杰.激素诱导的中心性浆液性脉络膜视网膜病变1例辨治与分析[J],2022,41(02):213-216.DOI:10.16295/j.cnki.0257-358x.2022.02.016.
基金信息:
国家自然科学基金面上项目（编号：81774370